Observational Trial With Leios/Alesse
Information source: Wyeth
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Contraceptives, Oral, Combined
Intervention: Leios/Alesse (Drug)
Phase: Phase 4
Status: Completed
Sponsored by: Wyeth Official(s) and/or principal investigator(s):
Medical Monitor, Study Director, Affiliation: Wyeth
Trial Manager, Principal Investigator, Affiliation: For Germany, medinfoDEU@wyeth.com
Summary
A prospective, observational study (Anwendungsbeobachtung [AWB]) of the prescribing and
administration practices of German gynecologists with Leios® Dragées.
Clinical Details
Official title: A Prospective Observation Study (Anwendungsbeobachtung [AWB]) of the Prescribing and Administration Practices of German Gynecologists With Leios® Dragées/Alesse
Study design: Prospective
Eligibility
Minimum age: N/A.
Maximum age: 40 Years.
Gender(s): Female.
Criteria:
Inclusion Criteria:
- Healthy, women, aged under 40
Locations and Contacts
Additional Information
Starting date: May 2005
Ending date: March 2007
Last updated: December 7, 2007
|
